Thymogen Overview, Dosing & Safety | Peptide Database

Thymogen (Thymagen)

EW Dipeptide | Thymus Immune Bioregulator

Community Research

Join others researching Thymogen — share findings, ask questions, and learn from real experiences

Thymogen (EW dipeptide) is a Khavinson bioregulator consisting of glutamic acid and tryptophan, originally isolated from calf thymus extracts (Thymalin) in the late 1980s. Developed by Professor Vladimir Khavinson, it has been registered in Russia since 1990 in multiple forms including injectable solution, nasal spray, and topical cream. Thymogen modulates both humoral and cellular immunity, activates T-cell differentiation, and has demonstrated geroprotective (anti-aging) and antitumor activities in research studies.

Thymogen works through multiple immunomodulatory mechanisms: (1) activates T-cell differentiation and T-cell recognition of peptide-MHC complexes, (2) induces changes in intracellular cyclic nucleotide composition, (3) activates neutrophilic chemotaxis and phagocytosis, (4) normalizes T-lymphocyte concentrations and ratios (CD3+, CD4+, CD8+), (5) stimulates production of immunoglobulins (IgA, IgG, IgE, IgM), and (6) enhances lymphocyte differentiation receptor expression. Research suggests Thymogen may interact specifically with the AACG DNA sequence, affecting gene expression. The peptide is rapidly distributed to thymus, lymph nodes, liver, adrenals, and kidneys.

Molecular Data

Glutamic Acid

Position 1

Trp (EW)

Position 2

Research Indications

Modulates both humoral and cellular immune responses for balanced immunity.

Activates T-cell differentiation and normalizes CD3+, CD4+, CD8+ populations.

Stimulates production of IgA, IgG, IgE, and IgM antibodies.

Studied for improving surgical outcomes through immune support.

Demonstrated geroprotector activity in aging research.

In combination with pineal peptides, showed significant mean lifespan increases in animal models.

Inhibits spontaneous carcinogenesis and shows robust antitumor effects in research.

Studied in Russia for regulating immune response in oncology patients.

Research interest in cardiovascular applications.

Investigated for metabolic and immune aspects of diabetes.

Dosing Protocols

Injectable form for intramuscular or subcutaneous administration. This is the original delivery method registered in Russia. Typical protocols involve 10-20 day cycles repeated 2-3 times per year.

Standard immune support

10-20 mg

Daily for 10-20 days

IM or SubQ

Maintenance protocol

20 mg

2-3 cycles per year

Reconstitution Instructions

Bacteriostatic water

Insulin syringes

Alcohol swabs

Sterile vial

1 Clean work area and hands

2 Reconstitute with bacteriostatic water

3 Inject slowly down vial wall

4 Gently swirl until dissolved

5 Store refrigerated at 2-8°C

6 Use within 4 weeks

Interactions

What to Expect

Side Effects & Safety

Common Side Effects

Generally well-tolerated

Injection site reactions (mild)

Minimal side effects reported in clinical use

Stop Signs - Discontinue if:

Signs of allergic reaction

Unusual immune symptoms

Severe injection site reactions

Contraindications

Active autoimmune diseases (use with caution)

Organ transplant recipients on immunosuppression

Known hypersensitivity to component amino acids

Pregnancy or breastfeeding

Quality Checklist

Good Signs

White to off-white lyophilized powder

Clear solution after reconstitution

Certificate of analysis with purity verification

Proper packaging and labeling

Warning Signs

Unknown source or unverified purity

Bad Signs

Discolored powder

Cloudy or particulate solution

Damaged packaging or broken seal

Frequently Asked Questions

What's the difference between Thymogen (EW dipeptide) and Thymalin (extract mixture)?

Thymogen is a single, pure dipeptide (Glu-Trp) isolated from Thymalin extracts. Thymalin is the complete mixture containing multiple peptides (KE, EW, EDP). Thymogen offers standardized dosing and stability, while Thymalin provides broader synergistic effects - both are compatible and sometimes used together.

Can Thymogen be taken orally or must it be injected?

Thymogen is available in multiple forms - oral capsules, injectable solution, nasal spray, and topical cream (all registered in Russia). The dipeptide's small size allows reasonable oral bioavailability via capsules, making it more convenient than injectable-only bioregulators.

How do Thymogen and Epitalon compare for anti-aging and lifespan extension?

Both are Khavinson anti-aging peptides with different targets. Thymogen focuses on immune rejuvenation and tumor suppression, while Epitalon targets pineal/endocrine aging. Combined use showed robust lifespan increases and antitumor activity in research models - they're synergistic rather than redundant.

Is Thymogen banned in sports like other immune peptides?

Thymogen is not explicitly listed as banned by WADA since it's not widely used in sports, but as a performance-enhancing immune modulator, it would likely be prohibited if tested. Check with your sport's governing body, but assume risk if subject to anti-doping testing.

References

Thymogen demonstrated geroprotector activity and inhibited spontaneous carcinogenesis in aging rat models.

Review of thymic peptide therapeutics including Thymogen for immune modulation.

Significant lifespan increases and antitumor activity with combined Thymogen and Epitalon treatment.

Thymogen activates T-cell differentiation, modulates cyclic nucleotides, and may interact with AACG DNA sequences.

Related Peptides

Combination showed significant lifespan increases and robust antitumor activity in research.

Thymogen was isolated from Thymalin; they share complementary thymus-supporting mechanisms.

Both are Khavinson thymus dipeptides; often combined in comprehensive immune protocols.

Different structures and mechanisms; can be used together.

Disclaimer

This information is for educational and research purposes only. Consult a healthcare professional before use.